Saipem’s merger with Subsea7 clears crucial US antitrust hurdle
What happened
Saipem and Subsea7 have cleared the U.S. Hart‑Scott‑Rodino waiting period, advancing the proposed merger one regulatory step closer to completion. The European Commission has opened an in‑depth review, so remedies or conditions are still to be determined. For procurement, watch whether the EU review forces divestments or remedies that change APAC shortlist composition
Why the category manager should care
Treat the merger as a material consolidation vector and start testing shortlist and bundling scenarios because it will affect allocation, pricing posture and unbundling ability
Key facts
- U.S. HSR waiting periods expired
- European Commission opened in‑depth review with remedies possible